CoChat

Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children

Dhawan, Anil, Chaijitraruch, Nataruks, Fitzpatrick, Emer, Bansal, Sanjay, Filippi, Celine, Lehec, Sharon C., Heaton, Nigel D., Kane, Pauline, Verma, Anita, Hughes, Robin D., Mitry, Ragai R. · 2020 · Journal of Hepatology
Cited by 109

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND Liver transplantation (LT) is the most effective treatment for patients with acute liver failure (ALF) though with the limitations of surgical risks and the need for life-long immunosuppression. Transplantation of microencapsulated human hepatocytes in alginate is an attractive option over whole liver replacement. The safety and efficacy of hepatocyte microbeads transplanted intraperitoneally has been shown in animal models. We report our experience of the use of this therapy in children with ALF on named patient basis under a MHRA Specials Manufacture License. METHODS Clinical grade human hepatocyte microbeads (HMBs) and empty microbeads (EMBs) were tested in immunocompetent healthy rats. Subsequently, eight children with ALF, who were awaiting a suitable allograft for LT, received intraperitoneal transplantation of HMBs. We monitored complications of the procedure, assessed the host immune response and residual function of the retrieved HMBs either after spontaneous native liver regeneration or at the time of LT. RESULTS Intraperitoneal transplantation of HMBs in healthy rats was safe with preserved synthetic and detoxification functions without the use of immunosuppression. Subsequently, eight children with ALF received HMBs (4 neonatal haemochromatosis, 2 viral infections and 2 children with unknown cause at time of infusion), median age of 14.5 days, range 1 day - 6 years. The procedure was well tolerated without complications. Of the 8 children, 4 avoided LT while 3 were successfully bridged to LT following the intervention. HMBs retrieved after infusions (at the time of LT) were structurally intact, free of host cell adherence and contained viable hepatocytes with preserved functions. CONCLUSION The results demonstrate the feasibility and safety of a HMB infusion in children with ALF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2019.12.002

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 109

Metadata

Authors
Dhawan, A., Chaijitraruch, N., Fitzpatrick, E., Bansal, S., Filippi, C., Lehec, S. C., Heaton, N. D., Kane, P., Verma, A., Hughes, R. D., & Mitry, R. R.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2020-05
Volume
72
Issue
5
Pages
877-884
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2994648584
Cited by
109
References
1
FWCI
7.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children. https://app.cochat.ai/papers/10.1016/j.jhep.2019.12.002
The paper
Dhawan, A., Chaijitraruch, N., Fitzpatrick, E., Bansal, S., Filippi, C., Lehec, S. C., Heaton, N. D., Kane, P., Verma, A., Hughes, R. D., & Mitry, R. R. (2020). Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2019.12.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.